Analytical Data
-
Gene name
C7orf30
- Application
-
Alternative Names
C7orf30; CG030_HUMAN; Chromosome 7 open reading frame 30; Uncharacterized Protein C7orf30
-
Species
Human
-
Source
E. coli
-
Tag
GST-tag at N-terminal
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q96EH3
-
Expression Region
1-234aa
-
AA Sequence
MGPGGRVARL LAPLMWRRAV SSVAGSAVGA EPGLRLLAVQ RLPVGAAFCR ACQTPNFVRG LHSEPGLEER AEGTVNEGRP ESDAADHTGP KFDIDMMVSL LRQENARDIC VIQVPPEMRY TDYFVIVSGT STRHLHAMAF YVVKMYKHLK CKRDPHVKIE GKDTDDWLCV DFGSMVIHLM LPETREIYEL EKLWTLRSYD DQLAQIAPET VPEDFILGIE DDTSSVTPVE LKCE
-
Molecular Weight
52.6 KDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
C7orf30, also known as Chromosome 7 Open Reading Frame 30, is a gene located on chromosome 7 that has garnered attention in the field of molecular biology due to its potential implications in various biological processes and diseases. Initial studies suggested that C7orf30 may be involved in cellular functions such as immune response regulation, cell proliferation, and apoptosis. Given its involvement in pathological conditions, including several types of cancer, researchers have been investigating the protein's structure and function to elucidate its role in these processes. The recombinant expression of C7orf30 allows for the production of the protein in a host system, facilitating detailed studies on its biochemical properties, interactions, and signaling pathways. Understanding the functional dynamics of C7orf30 is crucial, as it may reveal novel targets for therapeutic interventions and provide insights into disease mechanisms. Additionally, elucidating the molecular characteristics of C7orf30 can enhance our understanding of gene regulation and expression, contributing to the broader field of genetics and personalized medicine. This ongoing research aims to bridge the gap between basic science and clinical applications, potentially leading to significant advancements in treatment strategies for diseases associated with C7orf30 dysregulation. As a result, C7orf30 recombinant protein studies represent a vital component in unraveling complex biological networks and their implications in human health and disease.
